A novel liver-on-a-chip model can be used to study immune cell interactions in liver cancer and test promising new therapies.

A team led by Sylvain Meloche, Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signaling and Cell Growth ...

Hepatocellular carcinoma or HCC is the most commonly observed form of liver cancer and the fourth leading cause of ...

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...

Research Impact is a series that pulls back the curtain of IU Research, showcasing the faculty creating, innovating and ...

文章中，研究者发现，JUN蛋白在抑制YAP和TAZ上发挥着决定性的作用，这两种蛋白质在功能失调时都会强烈促进机体肿瘤的形成。这是研究人员在分析了8000多名患者的数据时偶然取得的这项新发现，同时他们也意识到了肝癌患者机体所出现的异常，这一研究发现为癌症研究提供了新的视野同时也有望帮助开发新型创新性疗法策略，这是因为靶向干预JUN蛋白的功能或能潜在控制甚至预防肝癌的进展。

Progression-free survival (PFS) in intermediate-stage hepatocellular carcinoma (HCC) improved by almost 5 months when a ...

Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.

TEXARKANA, Texas -- September is Childhood Cancer Awareness Month, and a teenager who was diagnosed with liver cancer twice ...

Excessive alcohol use may be one factor behind an increase in at least six cancers, including head and neck, esophageal, ...

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today presented positive, mature data from its ...